Skip to main content

Advertisement

SpringerLink
Log in

Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes

  • Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Aspirin allergy in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face. Adverse reactions to aspirin are reported in 1.5 % of patients with coronary artery disease. A history of adverse reaction to aspirin often leads to unnecessary withholding of this medication or use of alternative antiplatelet therapy which may be inferior or more costly. Aspirin therapy has been shown to reduce morbidity and mortality in patients with coronary artery disease. Rapid aspirin challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Amsterdam EA et al. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2354–94.

    Article  PubMed  Google Scholar 

  2. Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105:997–1001.

    Article  CAS  PubMed  Google Scholar 

  3. De Luca G, Verdoia M, Binda G, et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol. 2013;167(2):561–3.

    Article  PubMed  Google Scholar 

  4. McMullan KL, Wedner HJ. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol. 2013;36:25–30.

    Article  PubMed  Google Scholar 

  5. Rossini R, Angiolillo DJ, Musumeci G, et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101:786–9.

    Article  CAS  PubMed  Google Scholar 

  6. Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509–10.

    Article  CAS  PubMed  Google Scholar 

  7. Fajt ML, Petrov AA. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Crit Pathw Cardiol. 2011;10:17–21.

    Article  PubMed  Google Scholar 

  8. Cortellini G, Testi S, Severino M, et al. Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol. 2012;44(4):160–2.

    CAS  PubMed  Google Scholar 

  9. Dalmau G, Gaig P, Gazquez V, Merce J. Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance. Rev Esp Cardiol. 2009;62:224–5.

    Article  PubMed  Google Scholar 

  10. Ortega-Loayza AG, Raza S, Minisi AJ, et al. Aspirin desensitization/challenge in 3 patients with unstable angina. Am J Med Sci. 2010;340:418–20.

    Article  PubMed  Google Scholar 

  11. Christou A, Kafkas N, Marinakos A, et al. Rapid desensitisation of patients with aspirin allergy who undergo coronary angioplasty. Hell J Cardiol. 2011;52(4):307–10.

    Google Scholar 

  12. Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13e21.

    Article  Google Scholar 

  13. Feng CH, White AA, Stevenson DD. Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol. 2013;110(2):92–5. This article reviews 9,565 patients who were identified in a medical record with CAD and aspirin listed as an “allergy”. The article reports the nature of these reactions and also highlights the underutilization of aspirin challenge/desensitization.

    Article  CAS  PubMed  Google Scholar 

  14. Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug related problems. Drug Saf. 2000;22:415–23.

    Article  CAS  PubMed  Google Scholar 

  15. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017e3023.

    Article  Google Scholar 

  16. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–32. A comprehensive review describing the various hypersensitivity syndromes associated with aspirin and NSAIDs. Proposed diagnostic evaluation is also described.

    Article  CAS  PubMed  Google Scholar 

  17. Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676.

    Article  CAS  PubMed  Google Scholar 

  18. Mastalerz L, Setkowicz M, Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep. 2005;5(4):277–83.

    Article  CAS  PubMed  Google Scholar 

  19. Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol. 2015;15(4):314–22.

    Article  CAS  PubMed  Google Scholar 

  20. Katz Y, Goldberg N, Kivity S. Localized periorbital edema induced by aspirin. Allergy. 1993;48:366–9.

    Article  CAS  PubMed  Google Scholar 

  21. Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol. 2010;24:685–91.

    Article  CAS  PubMed  Google Scholar 

  22. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111:882–8.

    Article  CAS  PubMed  Google Scholar 

  23. Phills J, Perelmutter L. IgE and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol. 1974;29:474–9.

    Article  CAS  PubMed  Google Scholar 

  24. Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62:295–8.

    CAS  PubMed  Google Scholar 

  25. Aun MV, Blana M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol. 2014;2:414–20. A review of anaphylaxis caused by medications. In this review NSAIDs are noted to be the most frequent cause of anaphylaxis in patients presenting to the emergency department with a drug reaction. The article also reports an underutilization of epinephrine in patients presenting with anaphylaxis.

    Article  Google Scholar 

  26. Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67(3):206–13.

    Article  CAS  PubMed  Google Scholar 

  27. Aseros R. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2005;35:713–6.

    Article  Google Scholar 

  28. The CURRENT–OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363:10.

    Article  Google Scholar 

  29. Anderson JL, Adams CD, Antman EM. 2011 ACCF/AHA focused update on the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation. 2011;123:2022–60.

    Article  PubMed  Google Scholar 

  30. Kern M. Conversations in cardiology: what to do if your patient can’t take aspirin after stenting. Cath Lab Digest. 2014;22:10.

    Google Scholar 

  31. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011;3:3–10.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergy and Immunology, Scripps Green Hospital, La Jolla, CA, USA

    Kevin A. Cook & Andrew A. White

Authors
  1. Kevin A. Cook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew A. White
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew A. White.

Ethics declarations

Conflict of Interest

Drs. Cook and White declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Anaphylaxis and Drug Allergy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cook, K.A., White, A.A. Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes. Curr Allergy Asthma Rep 16, 11 (2016). https://doi.org/10.1007/s11882-015-0593-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-015-0593-2

Keywords

Search

Navigation